8-K - Corcept Therapeutics Incorporated | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

. Other Events. On January 22, 2026, Corcept Therapeutics Incorporated (the “Company”) issued a press release announcing that ROSELLA, the Company’s pivotal Pha

Other Event

9.01

. Financial Statements and Exhibits (d) Exhibits Exhibits No. Description 99.1 Press Release of Corcept Therapeutics Incorporated, January 22, 2026 104.1 Cover

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1